BioWorld MedTech

April 7, 2011

Emerge sees a need for line of generic orthopedic devices

A new medical device company has emerged with the goal of targeting the $2 billion orthopedic trauma market with the industry's first line of high-quality generic implants and instruments. (Medical Device Daily) Read More

VisualSonics developing new photoacoustics imaging tool

International report: Volcano cleared to market PrimeWire Prestige in Japan

Shuren says start date of new harmonization body uncertain

Deals roundup: LabCorp to acquire OC shares for $85 million

MDD's food for med-tech thought

Agreements/contracts: GE partners with TomTec to 'enhance patient care'

Court Report: Hospital to pay $1.9M to settle Medicare fraud charges

Med-Tech Notes

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Nov. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for November 27, 2024.

Illustration of man holding magnifying glass to human body model showing muscle anatomy

In muscular dystrophies, gene therapies race the clock

BioWorld

Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...

AI-generated illustration of heart and metabolic impact

Bridgebio, with FDA approval, faces Pfizer in ATTR

BioWorld

With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...

‘Evo’ AI can design complete genomes

BioWorld Science

The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...